This would give an idea on the value of the company and what it is trying to achieve. Back in January, Lumiradx was to be acquired by a big player in the diagnostics industry Roche. 318Million shares outstanding and a purchase price of $295Million. Annual revenue 2023 of $125MillionUSD.
Roche Purchase
If Febridx and Viradx can produce reasonable revenues over the next few quarters coupled with FFN testing etc, I cant see why they couldn't achieve similar levels.
- Forums
- ASX - By Stock
- Ann: Lumos Receives US$400k Phase 1 Milestone from Hologic
This would give an idea on the value of the company and what it...
-
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LDX (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.80M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 105000 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.8¢ | 352408 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 105000 | 0.038 |
3 | 402500 | 0.037 |
3 | 223596 | 0.036 |
3 | 192905 | 0.035 |
3 | 503841 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.038 | 352408 | 1 |
0.041 | 239108 | 2 |
0.042 | 676288 | 3 |
0.045 | 100000 | 1 |
0.046 | 100000 | 1 |
Last trade - 09.50am 26/08/2024 (20 minute delay) ? |
Featured News
LDX (ASX) Chart |
Day chart unavailable
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online